Following on from the 2015 Lancet Oncology Commission on expanding global access to
radiotherapy, Radiotherapy and theranostics: a Lancet Oncology Commission was created …

The use of total body irradiation as part of conditioning regimens for acute leukaemia is
progressively declining because of concerns of late toxic effects and the introduction of …

Radiation therapy is one of the core components of multidisciplinary cancer care. Although~
50% of all European cancer patients have an indication for radiotherapy at least once in the …

Background and purpose Multiple large trials have established the non-inferiority of
hypofractionated radiotherapy compared to conventional fractionation. This study will …

Prostate cancer (PCa) is the most common non-cutaneous cancer in men in Europe and is
predicted to exhibit declining mortality in the European Union (EU) due to various recent …

Background Large-scale trials have shown that hypofractionated adjuvant breast
radiotherapy was as effective in terms of survival and local control as conventional …

Purpose Magnetic resonance image (MRI)-guided radiation therapy with the 1.5 Tesla
magnetic resonance linear accelerator (MR-Linac) is a rapidly evolving and emerging …

Background and purpose Complex surgery and radiotherapy are the central pillars of loco-
regional oncology treatment. This paper describes the reimbursement schemes used in …

In Europe, inappropriate reimbursement and funding rules and regulations act as
disincentives to best breast cancer care or, at worst, hinder best care. This problem was the …

Radiotherapy interventions are rapidly evolving and improving, holding promise for better
patient outcomes, yet at the possible detriment of higher societal costs. The ESTRO-HERO …